Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
0.11 EUR | -2.65% | -6.61% | -33.21% |
2023 | Valerio Therapeutics Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
2023 | Onxeo SA has Changed its Name to Valerio Therapeutics | CI |
Sales 2021 | 4.06M 4.36M | Sales 2022 | 1.44M 1.55M | Capitalization | 15.64M 16.78M |
---|---|---|---|---|---|
Net income 2021 | -5M -5.36M | Net income 2022 | -19M -20.39M | EV / Sales 2021 | 7.53 x |
Net cash position 2021 | 7.95M 8.53M | Net cash position 2022 | 4.45M 4.78M | EV / Sales 2022 | 7.75 x |
P/E ratio 2021 |
-6
x | P/E ratio 2022 |
-0.76
x | Employees | 39 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 73.93% |
1 day | -2.30% | ||
1 week | -6.44% | ||
Current month | +2.22% | ||
1 month | +12.42% | ||
3 months | -12.38% | ||
6 months | -33.69% | ||
Current year | -33.09% |
Managers | Title | Age | Since |
---|---|---|---|
Shefali Agarwal
CEO | Chief Executive Officer | 50 | 21-05-31 |
Ashish Gulati
CTO | Chief Tech/Sci/R&D Officer | - | - |
Julien Miara
BRD | Director/Board Member | - | 20-09-16 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jacques Mallet
BRD | Director/Board Member | 64 | 21-10-13 |
Khalil Barrage
BRD | Director/Board Member | 59 | - |
Director/Board Member | 60 | 11-06-28 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 0.11 | -2.65% | 66 592 |
24-04-25 | 0.113 | -1.74% | 44,782 |
24-04-24 | 0.115 | -0.86% | 27,666 |
24-04-23 | 0.116 | -0.17% | 54,566 |
24-04-22 | 0.1162 | -1.53% | 22,129 |
Real-time Euronext Paris, April 26, 2024 at 03:09 am EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-33.09% | 18.65M | |
+24.65% | 556B | |
-6.33% | 354B | |
+19.90% | 331B | |
+7.95% | 296B | |
+13.28% | 233B | |
+5.62% | 201B | |
-10.22% | 193B | |
-12.26% | 143B | |
-6.47% | 144B |
- Stock Market
- Equities
- ALVIO Stock